StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.01 (-1.40%)

Close on Nov 18, 2026Market cap $1.27MP/E –Yield –

Scinai Immunotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Scinai Immunotherapeutics's market cap was $2.90M on Nov 11, 2026, against $15.60M a year earlier. Over the last 5 years it ranged from $2.69M to $306.71M, with a median of $28.01M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.90M-73.1%
2025Dec 31, 2025$10.78M-61.5%
2024Dec 31, 2024$28.01M+29.4%
2023Dec 29, 2023$21.64M-48.2%
2022Dec 30, 2022$41.78M-84.0%
2021Dec 31, 2021$260.42M+13.5%
2020Dec 31, 2020$229.47M-62.2%
2019Dec 31, 2019$607.15M+153.3%
2018Dec 31, 2018$239.73M+32.4%
2017Dec 29, 2017$181.03M+104.8%
2016Dec 30, 2016$88.38M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?